AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie Inc Price Live Data
The current price of AbbVie Inc in the market is $233.47, with a 24-hour trading volume of $1.52B. The asset's market cap is $412.44B, after moving -1.12% in the last day.
Tokenized AbbVie Inc is trading at $233.62, with a tokenized market cap of $794.32K and a 24-hour trading volume of $543.29K. The tokenized asset has moved -1.17% in the past 24 hours.